Eyenovia (EYEN) Projected to Post Earnings on Monday

Eyenovia (NASDAQ:EYEN) is anticipated to release its earnings data before the market opens on Monday, March 17th. Analysts expect Eyenovia to post earnings of ($8.00) per share and revenue of $1.60 million for the quarter.

Eyenovia Trading Down 2.5 %

Shares of EYEN opened at $1.59 on Monday. The business’s 50-day moving average price is $4.36 and its 200-day moving average price is $20.59. Eyenovia has a twelve month low of $1.43 and a twelve month high of $142.40. The stock has a market cap of $2.21 million, a PE ratio of -0.03 and a beta of 1.29. The company has a quick ratio of 0.55, a current ratio of 0.74 and a debt-to-equity ratio of 0.58.

Analysts Set New Price Targets

Several research firms recently weighed in on EYEN. HC Wainwright restated a “neutral” rating and issued a $2.00 price objective on shares of Eyenovia in a research report on Thursday, February 6th. Brookline Capital Management restated a “hold” rating on shares of Eyenovia in a research report on Friday, November 15th. LADENBURG THALM/SH SH restated a “neutral” rating on shares of Eyenovia in a research report on Monday, November 18th. Finally, William Blair reaffirmed a “market perform” rating on shares of Eyenovia in a research note on Friday, November 15th.

Eyenovia Company Profile

Eyenovia, Inc, an ophthalmic technology company, engages in the development of therapeutics based on its proprietary microdose array print platform technology. The company's product candidates include MicroPine, which is in Phase III clinical development program with indications for pediatric myopia progression (near-sightedness); MicroLine, which is in Phase III clinical development program with indications for the improvement in near vision in people with presbyopia; and Mydcombi, which is in Phase III clinical development program with indications for pharmaceutical mydriasis.